The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Provides an intuitive framework for ad-hoc statistical analysis of 1H-NMR metabolomics by Nightingale Health. It allows to easily explore new metabolomics measurements assayed by Nightingale Health, comparing the distributions with a large Consortium (BBMRI-nl); project previously published metabolic scores [<doi:10.1016/j.ebiom.2021.103764>, <doi:10.1161/CIRCGEN.119.002610>, <doi:10.1038/s41467-019-11311-9>, <doi:10.7554/eLife.63033>, <doi:10.1161/CIRCULATIONAHA.114.013116>, <doi:10.1007/s00125-019-05001-w>]; and calibrate the metabolic surrogate values to a desired dataset.
Version: | 1.5 |
Depends: | R (≥ 4.1.0) |
Imports: | caret, DT, foreach, ggplot2, heatmaply, matrixStats, plotly, pROC, purrr, shiny, shinycssloaders, shinyFiles, shinydashboard, shinyjs, shinyWidgets, stats, survival, survminer, dplyr, fs |
Suggests: | testthat (≥ 3.0.0), ggfortify, knitr, rmarkdown |
Published: | 2024-02-01 |
DOI: | 10.32614/CRAN.package.MiMIR |
Author: | Daniele Bizzarri [aut, cre], Marcel Reinders [aut, ths], Marian Beekman [aut], Pieternella Eline Slagboom [aut, ths], Erik van den Akker [aut, ths] |
Maintainer: | Daniele Bizzarri <d.bizzarri at lumc.nl> |
License: | GPL-3 |
NeedsCompilation: | no |
Materials: | README NEWS |
CRAN checks: | MiMIR results |
Reference manual: | MiMIR.pdf |
Package source: | MiMIR_1.5.tar.gz |
Windows binaries: | r-devel: MiMIR_1.5.zip, r-release: MiMIR_1.5.zip, r-oldrel: MiMIR_1.5.zip |
macOS binaries: | r-release (arm64): MiMIR_1.5.tgz, r-oldrel (arm64): MiMIR_1.5.tgz, r-release (x86_64): MiMIR_1.5.tgz, r-oldrel (x86_64): MiMIR_1.5.tgz |
Old sources: | MiMIR archive |
Please use the canonical form https://CRAN.R-project.org/package=MiMIR to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.